Barclays PLC Raises Holdings in Cardinal Health, Inc. (NYSE:CAH)

Barclays PLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 707,404 shares of the company's stock after purchasing an additional 53,851 shares during the quarter. Barclays PLC owned 0.29% of Cardinal Health worth $78,183,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $25,000. Cultivar Capital Inc. purchased a new stake in shares of Cardinal Health during the 2nd quarter worth $27,000. Frazier Financial Advisors LLC grew its stake in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after purchasing an additional 104 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in Cardinal Health during the second quarter worth about $29,000. Finally, Hara Capital LLC acquired a new position in Cardinal Health during the third quarter worth about $31,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Price Performance

CAH traded up $0.04 during trading on Thursday, hitting $117.46. The company's stock had a trading volume of 2,998,563 shares, compared to its average volume of 2,103,671. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $126.23. The stock has a market cap of $28.43 billion, a PE ratio of 22.84, a PEG ratio of 1.53 and a beta of 0.61. The firm's 50 day moving average price is $116.86 and its 200-day moving average price is $108.14.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same period in the prior year, the firm posted $1.73 earnings per share. The business's quarterly revenue was down 4.3% compared to the same quarter last year. Equities analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.72%. Cardinal Health's dividend payout ratio is presently 39.30%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Argus boosted their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, September 11th. Wells Fargo & Company upped their target price on Cardinal Health from $95.00 to $101.00 and gave the company an "underweight" rating in a report on Thursday, August 15th. Morgan Stanley lifted their price target on Cardinal Health from $119.00 to $127.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price objective on the stock. Finally, UBS Group lifted their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $124.58.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.